These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1384157

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age.
    Fatah K, Silveira A, Tornvall P, Karpe F, Blombäck M, Hamsten A.
    Thromb Haemost; 1996 Oct; 76(4):535-40. PubMed ID: 8902992
    [Abstract] [Full Text] [Related]

  • 3. Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency?
    Colle JP, Mishal Z, Lesty C, Mirshahi M, Peyne J, Baumelou A, Bensman A, Soria J, Soria C.
    Thromb Haemost; 1999 Nov; 82(5):1482-9. PubMed ID: 10595642
    [Abstract] [Full Text] [Related]

  • 4. Fibrinogen and other coronary risk factors.
    Von Eyben FE, Mouritsen EA, Holm J, Montvilas P, Dimcevski G, Rasmussen IH, Kristensen LL, Suciu G, Von Eyben R.
    Metabolism; 2005 Feb; 54(2):165-70. PubMed ID: 15690309
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
    Mendoza SG, Zerpa A, Carrasco H, Colmenares O, Rangel A, Gartside PS, Kashyap ML.
    Artery; 1983 Feb; 12(1):1-23. PubMed ID: 6431945
    [Abstract] [Full Text] [Related]

  • 9. Marked increase of fibrin gel permeability with very low dose ASA treatment.
    Antovic A, Perneby C, Ekman GJ, Wallen HN, Hjemdahl P, Blombäck M, He S.
    Thromb Res; 2005 Feb; 116(6):509-17. PubMed ID: 16181986
    [Abstract] [Full Text] [Related]

  • 10. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.
    Bröijersén A, Hamsten A, Silveira A, Fatah K, Goodall AH, Eriksson M, Angelin B, Hjemdahl P.
    Thromb Haemost; 1996 Aug; 76(2):171-6. PubMed ID: 8865525
    [Abstract] [Full Text] [Related]

  • 11. Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis.
    He S, Bark N, Wang H, Svensson J, Blombäck M.
    J Cardiovasc Pharmacol; 2009 Jan; 53(1):24-9. PubMed ID: 19129740
    [Abstract] [Full Text] [Related]

  • 12. [Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
    Dudaev VA, Diukov IV, Borodkin VV.
    Ter Arkh; 1986 Jan; 58(12):62-7. PubMed ID: 3824217
    [Abstract] [Full Text] [Related]

  • 13. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.
    Stompór T, Pasowicz M, Sulłowicz W, Dembińska-Kieć A, Janda K, Wójcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E.
    Am J Kidney Dis; 2003 Jan; 41(1):203-11. PubMed ID: 12500238
    [Abstract] [Full Text] [Related]

  • 14. The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects.
    Pieters M, Covic N, Loots du T, van der Westhuizen FH, van Zyl DG, Rheeder P, Jerling JC, Weisel JW.
    Thromb Haemost; 2006 Nov; 96(5):623-9. PubMed ID: 17080220
    [Abstract] [Full Text] [Related]

  • 15. Plasma procarboxypeptidase U in men with symptomatic coronary artery disease.
    Silveira A, Schatteman K, Goossens F, Moor E, Scharpé S, Strömqvist M, Hendriks D, Hamsten A.
    Thromb Haemost; 2000 Sep; 84(3):364-8. PubMed ID: 11019956
    [Abstract] [Full Text] [Related]

  • 16. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.
    Assmann G, Cullen P, Heinrich J, Schulte H.
    Isr J Med Sci; 1996 Jun; 32(6):364-70. PubMed ID: 8682642
    [Abstract] [Full Text] [Related]

  • 17. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
    Undas A, Brozek J, Jankowski M, Siudak Z, Szczeklik A, Jakubowski H.
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890
    [Abstract] [Full Text] [Related]

  • 18. Myocardial infarction in patients aged less than 40 years. Frequency of BclI polymorphism in the fibrinogen beta-chain gene and plasma fibrinogen.
    Lewandowski K, Kwaśnikowski P, Elikowski W, Zawilska K.
    Kardiol Pol; 2003 Sep; 59(9):205-12. PubMed ID: 14618197
    [Abstract] [Full Text] [Related]

  • 19. Native fibrin gel networks and factors influencing their formation in health and disease.
    Blombäck B, Banerjee D, Carlsson K, Hamsten A, Hessel B, Procyk R, Silveira A, Zacharski L.
    Adv Exp Med Biol; 1990 Sep; 281():1-23. PubMed ID: 2129366
    [Abstract] [Full Text] [Related]

  • 20. Fibrinogen Caracas I: a dysfibrinogenemia with a hemorrhagic diathesis associated with diminished fibrin fiber diameter and reduced fibrin gel porosity.
    Marchi R, Lundberg U, de Bosch NB, Arocha-Piñango CL.
    Blood Coagul Fibrinolysis; 1998 Nov; 9(8):733-9. PubMed ID: 9890716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.